ABEO: Abeona Therapeutics Inc

ABEO新闻

• Investing 11:50 H.C. Wainwright maintains Buy rating on Abeona Therapeutics stock despite FDA setback
• Investing 11:09 Bio-techne’s technology supports FDA approval of rare skin disorder therapy
• Investing 11:41 Abeona therapeutics closes sale of priority review voucher for $155 million
• Investing 11:35 Beacon Therapeutics licenses Abeona’s AAV204 capsid for retinal therapies
• Investing 11:43 Abeona Therapeutics ® added to Membership of U.S. Small-cap Russell 2000 ® Index and Broad-market Russell 3000 ® Index
• Investing 11:48 Abeona Therapeutics ® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa
• Seeking Alpha 09:22 Abeona Therapeutics' Zevaskyn Vs. Krystal Biotech's Vyjuvek (KRYS, ABEO)
• Seeking Alpha 21:18 Capricor: A Hold Rating With Regulatory FDA Form Given For Deramiocel Advancement (CAPR)
• Seeking Alpha 09:48 Abeona Therapeutics: Substantially Undervalued Post-FDA Approval (ABEO)
• Investing 18:05 Abeona Therapeutics at Jefferies Conference: ZivaSkin’s Promising Launch
• Investing 13:38 Oppenheimer assumes coverage on Abeona Therapeutics stock
• Investing 11:54 Abeona Therapeutics ® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Investing 12:56 Abeona Therapeutics ®  to Present at the Jefferies Global Healthcare Conference
• Benzinga 12:13 PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Abeona Therapeutics (NASDAQ:ABEO), Ascentage Pharma Group (NASDAQ:AAPG)
• Investing 14:24 Stifel cuts Abeona Therapeutics price target to $20, maintains Buy
• Investing 16:20 Earnings call transcript: Abeona Therapeutics beats EPS forecast in Q1 2025
• Investing 11:40 Abeona Therapeutics ® Reports First Quarter 2025 Financial Results and Corporate Updates
• Benzinga 20:41 Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease - Abeona Therapeutics (NASDAQ:ABEO)
• Benzinga 18:44 Abeona Stock Surges to 52-Week High: What's Behind The Move? - Abeona Therapeutics (NASDAQ:ABEO)
• Benzinga 19:06 Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy - Abeona Therapeutics (NASDAQ:ABEO)
• Seeking Alpha 12:30 Undercovered Dozen: 3D Systems, Seritage, Topicus, Timken +
• Seeking Alpha 14:00 Abeona: pz-cel Has Massive Potential For RDEB Patients (NASDAQ:ABEO)
• Seeking Alpha 11:11 Abeona Therapeutics: An Uncertain Pivotal Regulatory Catalyst With Limited Upside (ABEO)
• Seeking Alpha 15:39 Abeona Stock: A Buy With Major PDUFA Catalyst On April 29 That Should Send Shares Higher